Literature DB >> 31298480

Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells.

Hongliang Liu1,2,3, Jiajia Cui1,2,3, Yuliang Zhang1,2,3, Min Niu1,2,3, Xuting Xue1,2,3, Hongyu Yin1,2,3, Yemei Tang1,2,3, Li Dai1,2,3, Fengsheng Dai1,2,3, Yujia Guo1,2,3, Yongyan Wu1,2,3, Wei Gao1,2,3.   

Abstract

Fascin actin-bundling protein 1 (FSCN1) is an evolutionarily conserved actin-bundling protein that plays a critical role in cell migration, motility, adhesion, and cellular interactions. Although multiple clinical studies have implicated the expression of FSCN1 in laryngeal squamous cell carcinoma (LSCC) progression, the precise mechanism of FSCN1 in the process has not been clearly elucidated. To define FSCN1 function, we characterized FSCN1‐interacting proteins in two cell lines by immunoprecipitation followed by mass spectrometry (MS). After data filtering, 119 proteins with expression in both the Hep-2 and TU-177 cell samples were identified as FSCN1-interacting partners. With in-depth bioinformatics analysis, we linked FSCN1 to critical cellular processes including cell adhesion, glycolysis/gluconeogenesis, regulation of protein ubiquitination, ribosomal RNA processing, and small molecule metabolism. We discuss the interactions between FSCN1 and some of the newly validated partners. The identification of these potential partners of FSCN1 expands our knowledge of the FSCN1 interactome and provides a valuable resource for understanding the functions of this protein in LSCC progression.
© 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  FSCN1; coimmunoprecipitation; interacting partners; laryngeal squamous cell carcinoma; mass spectrometry; proteomics

Mesh:

Substances:

Year:  2019        PMID: 31298480     DOI: 10.1002/iub.2121

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  11 in total

Review 1.  The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis.

Authors:  Zhi-Da Zhang; Rong-Rong Li; Jia-You Chen; Hong-Xin Huang; Yin-Wei Cheng; Li-Yan Xu; En-Min Li
Journal:  Amino Acids       Date:  2022-08-08       Impact factor: 3.789

2.  Larynx proteomics after jellyfish collagen IL: Increased ECM/collagen and suppressed inflammation.

Authors:  Andrew J Bowen; Dale C Ekbom; Danielle Hunter; Stephen Voss; Kathleen Bartemes; Andrew Mearns-Spragg; Michael S Oldenburg; Serban San-Marina
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-24

Review 3.  FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Authors:  Zhongxun Li; Jiao Shi; Nannan Zhang; Xiwang Zheng; Yukun Jin; Shuxin Wen; Wanglai Hu; Yongyan Wu; Wei Gao
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

4.  Circulating Actin-Binding Proteins in Laryngeal Cancer: Its Relationship with Circulating Tumor Cells and Cells of the Immune System.

Authors:  G V Kakurina; M N Stakheeva; I A Bakhronov; E E Sereda; O V Cheremisina; E L Choynzonov; I V Kondakova
Journal:  Acta Naturae       Date:  2021 Oct-Dec       Impact factor: 1.845

5.  TBC1D10C is a cytoskeletal functional linker that modulates cell spreading and phagocytosis in macrophages.

Authors:  Fabian R Villagomez; Juan D Diaz-Valencia; Erasmo Ovalle-García; Armando Antillón; Iván Ortega-Blake; Héctor Romero-Ramírez; Jorge F Cerna-Cortes; Roberto Rosales-Reyes; Leopoldo Santos-Argumedo; Genaro Patiño-López
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

6.  Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis.

Authors:  Cong Chen; Bojian Xie; Zhaoqing Li; Lini Chen; Yongxia Chen; Jichun Zhou; Siwei Ju; Yulu Zhou; Xun Zhang; Wenying Zhuo; Jingjing Yang; Misha Mao; Ling Xu; Linbo Wang
Journal:  Cell Death Dis       Date:  2022-02-14       Impact factor: 8.469

7.  Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.

Authors:  Guojin Zhou; Shoude Zhang; Mao Jin; Sunhong Hu
Journal:  BMC Cancer       Date:  2022-06-17       Impact factor: 4.638

Review 8.  How does fascin promote cancer metastasis?

Authors:  Shengchen Lin; Matthew D Taylor; Pankaj K Singh; Shengyu Yang
Journal:  FEBS J       Date:  2020-07-23       Impact factor: 5.542

Review 9.  Fascin in Cell Migration: More Than an Actin Bundling Protein.

Authors:  Maureen C Lamb; Tina L Tootle
Journal:  Biology (Basel)       Date:  2020-11-17

10.  LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism.

Authors:  Yupeng Wu; Yu Zhou; Haiying Gao; Yajun Wang; Qingyu Cheng; Shikun Jian; Qi Ding; Wei Gu; Yanxue Yao; Jia Ma; Wenjuan Wu; Yuyun Li; Xuhui Tong; Xiaoyuan Song; Sai Ma
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.